Boston Scientific discloses compliance with FTC second request for Axonics deal
Medical device giant Boston Scientific said it has complied with the US Federal Trade Commission’s request for additional information for its proposed acquisition of Axonics. The company reaffirmed its expectation that...To view the full article, register now.
Already a subscriber? Click here to view full article